JHLT: The Podcast covers a long-term follow up of the SCHEDULE trial
On the second December episode of JHLT: The Podcast, the Digital Media Editors explore another paper from the December issue of JHLT, entitled "Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial."
You can also stream the podcast on Spotify, Amazon, iTunes, and anywhere else you get podcasts.
First author Entela Bollano, MD, PhD, and senior author Niklas Bergh, MD, PhD, both from the Sahlgrenska University Hospital in Sweden, join the podcast to discus their work.
The episode explores:
- Past outcomes of the SCHEDULE trial, including reduced CAV in patients on everolimus over patients on CNIs
- How this study filled the need for long-term follow up on randomized studies on immunosuppression
- Limitations of the study, and what additional follow up might teach us
For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you’re an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
Don’t already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.